ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ICOS Icos

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Icos NASDAQ:ICOS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

ICOS to Participate in Upcoming Healthcare Conference

23/02/2006 1:00am

Business Wire


Icos (NASDAQ:ICOS)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Icos Charts.
ICOS Corporation (Nasdaq:ICOS) announced today that it will participate in the Cowen & Co. Healthcare Conference on Thursday, March 9, 2006. The presentation, which may include a discussion of financial guidance and future plans, will be webcast. -0- *T Cowen & Co. Healthcare Conference Presentation Date: March 9, 2006 Time: 9:40 a.m. Eastern Time Speaker: Michael A. Stein, Senior Vice President and Chief Financial Officer A webcast of this ICOS presentation will be available in real-time and a replay will be available through March 16, 2006. The webcast can be accessed through the ICOS Web site, www.icos.com, Investor -- Events section. *T Additional information on ICOS, including past press releases, is also available at www.icos.com. About ICOS Corporation: ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is marketing its first product, Cialis(R) (tadalafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical needs such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer and inflammatory diseases. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause ICOS' results and the timing of certain events to differ materially from those discussed in the forward-looking statements, including risks associated with product commercialization, manufacturing activities, clinical development, regulatory approvals, intellectual property claims and litigation and other risks detailed in ICOS' latest Quarterly Report on Form 10-Q and its other SEC filings.

1 Year Icos Chart

1 Year Icos Chart

1 Month Icos Chart

1 Month Icos Chart

Your Recent History

Delayed Upgrade Clock